SecSonar.com

Amneal Pharmaceuticals, Inc. (AMRX)

Amneal Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Amneal Pharmaceuticals, Inc. (AMRX) is a Drug Manufacturers - Specialty & Generic company based in US with a market capitalization of $4.2B. Revenue grew 8.1% year-over-year and the company generated $269.9M in free cash flow. This page tracks AMRX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 8.3K employees · IPO May 7, 2018

Valuation

Valuation & price

$11.93 · as of May 17, 2026 · -31.1% vs 52w high

53.8

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$17.27$12.54$7.82Jul 25Dec 25Jul 26Jul 7, 25$8.41Jul 9, 25$8.33Jul 11, 25$8.33Jul 15, 25$8.27Jul 17, 25$8.24Jul 21, 25$7.91Jul 23, 25$8.07Jul 25, 25$8.06Jul 29, 25$8.09Jul 31, 25$7.82Aug 4, 25$7.96Aug 6, 25$8.05Aug 11, 25$8.84Aug 13, 25$9.40Aug 15, 25$9.45Aug 19, 25$9.33Aug 21, 25$9.53Aug 25, 25$9.28Aug 27, 25$9.36Aug 29, 25$9.56Sep 3, 25$9.54Sep 5, 25$9.62Sep 9, 25$9.89Sep 11, 25$10.09Sep 16, 25$9.74Sep 18, 25$9.81Sep 22, 25$10.00Sep 24, 25$9.71Sep 26, 25$9.75Sep 30, 25$10.01Oct 2, 25$10.40Oct 6, 25$10.55Oct 8, 25$10.48Oct 10, 25$9.97Oct 14, 25$9.72Oct 16, 25$9.87Oct 21, 25$10.29Oct 23, 25$10.42Oct 27, 25$10.25Oct 29, 25$10.43Oct 31, 25$10.82Nov 4, 25$11.35Nov 6, 25$11.66Nov 10, 25$11.48Nov 12, 25$11.90Nov 14, 25$11.64Nov 18, 25$11.57Nov 20, 25$11.52Nov 25, 25$12.44Nov 28, 25$12.52Dec 2, 25$12.00Dec 4, 25$11.94Dec 8, 25$11.87Dec 10, 25$12.21Dec 12, 25$12.21Dec 16, 25$12.17Dec 18, 25$12.64Dec 22, 25$12.82Dec 24, 25$12.87Dec 29, 25$12.91Jan 2, 26$12.66Jan 6, 26$12.99Jan 8, 26$13.20Jan 12, 26$12.98Jan 14, 26$13.25Jan 16, 26$13.41Jan 21, 26$13.71Jan 23, 26$13.39Jan 27, 26$13.83Jan 29, 26$14.11Feb 2, 26$14.19Feb 4, 26$14.43Feb 9, 26$14.52Feb 11, 26$14.70Feb 13, 26$14.82Feb 18, 26$14.85Feb 20, 26$14.50Feb 24, 26$14.66Feb 26, 26$14.49Mar 2, 26$13.77Mar 4, 26$13.30Mar 6, 26$13.24Mar 10, 26$13.35Mar 12, 26$12.12Mar 17, 26$12.43Mar 19, 26$12.34Mar 23, 26$11.92Mar 25, 26$12.26Mar 27, 26$11.85Mar 31, 26$12.43Apr 2, 26$12.48Apr 7, 26$12.32Apr 9, 26$12.80Apr 13, 26$12.83Apr 15, 26$13.05Apr 17, 26$13.91Apr 22, 26$12.82Apr 24, 26$12.52Apr 28, 26$12.74Apr 30, 26$12.87May 4, 26$13.11May 6, 26$13.62May 8, 26$13.20May 12, 26$12.60May 14, 26$12.23May 18, 26$11.92May 20, 26$12.23May 22, 26$12.42May 28, 26$12.95Jun 1, 26$12.90Jun 3, 26$12.88Jun 5, 26$13.75Jun 9, 26$14.69Jun 11, 26$16.34Jun 15, 26$16.24Jun 17, 26$16.28Jun 22, 26$16.11Jun 24, 26$17.27Jun 26, 26$17.23Jul 2, 26$17.15
$7.8252-week range$17.32
Loading valuation history…

Fundamentals

Key fundamentals

$4.2B

Market cap

8.1%

Revenue growth (YoY)

37.6%

Gross margin

$269.9M

Free cash flow (USD)

$2.4B

Net debt

1.4%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.0BFY 2017$1.0BFY 2018$1.7BFY 2019$1.6BFY 2020$2.0BFY 2021$2.1BFY 2022$2.2BFY 2023$2.4BFY 2024$2.8BFY 2025$3.0B
$1B$3B

Free cash flow by year

2016 → 2025

FY 2016$-9.5MFY 2017$119.9MFY 2018$153.1MFY 2019$-95.7MFY 2020$317.2MFY 2021$194.1MFY 2022$-25.5MFY 2023$276.4MFY 2024$220.1MFY 2025$269.9M
-$9.5M$269.9M

Gross margin by year

2021 → 2025

FY 202136.7%FY 202235.8%FY 202336.1%FY 202436.5%FY 202537.6%
36.7%37.6%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 7, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $451KAutor Deborah M. · Director · $450.6KMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 7, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 7, 2026Filing
  • Quarterly report10-Q FiledMay 7, 2026Filing
  • 8-K eventAcquisition AnnouncedApr 22, 2026Filing

Questions

Frequently asked questions

What is Amneal Pharmaceuticals, Inc.'s market cap?

Amneal Pharmaceuticals, Inc. (AMRX) has a market capitalization of $4.2B.

What is AMRX's P/E ratio?

AMRX trades at a price-to-earnings ratio of 53.8, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

Are insiders buying AMRX stock?

SEC Form 4 filings show no open-market insider buys at Amneal Pharmaceuticals, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

INDV

Indivior Pharmaceuticals Inc

$4.5B

SUPN

Supernus Pharmaceuticals, Inc.

$2.7B

HCM

HUTCHMED (China) Limited

$2B

BHC

Bausch Health Companies Inc.

$2B

LNTH

Lantheus Holdings, Inc.

$6.5B

ANIP

ANI Pharmaceuticals, Inc.

$1.8B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.